NTLA
Intellia Therapeutics, Inc. · Healthcare
EVP and Chief Medical Officer David Lebwohl sold $110K of Intellia Therapeutics, Inc.
Sold$109,627
$9.21Price
11,903Shares
−9%Stake
What NTLA did after the filing
- The stock from Wed, Jan 7 close, $10.13
- +24.8%
- S&P 500, same days
- 0.0%
Measured over 30 trading days, to the Feb 20 close.
Traded Mon, Jan 5. Filed Wed, Jan 7, 11:04 AM ET, during the session. Returns use the Jan 7 close and the Feb 20 close. Not investment advice.